Laboratory in Diagnosis and Monitoring of Systemic Inflammatory Response Syndrome or Sepsis

Hale Aral 1 *
More Detail
1 Sağlık Bakanlığı, İstanbul Fatih Kamu Hastaneler Birliği, İstanbul Eğitim ve Araştırma Hastanesi, Tıbbi Biyokimya Bölümü
* Corresponding Author
EUR J BASIC MED SCI, Volume 5, Issue 1, pp. 10-20. https://doi.org/10.15197/sabad.2.5.02
OPEN ACCESS
Download Full Text (PDF)

ABSTRACT

Systemic Inflammatory Response Syndrome (SIRS) is a delocalized, dysregulated inflammatory response of high intensity to various stimuli. It leads to disorders of microcirculation, organ perfusion and finally to secondary organ dysfunction. When infection is also added, sepsis is a condition that affects not only the immune system but also other biological systems, such as the coagulation system and the autonomic nervous system. Laboratory analysis of blood gasses, electrolytes indicating water-electrolyte and acid-base balance; glucose and lactate related with metabolic status; complete blood count and indices appeared in the early phase systemic inflammation; coagulation tests and thromboelastographic examination; biomarkers of CRP, cytokines, procalcitonin and serum creatinine levels may be requested for diagnosis and followup of SIRS, sepsis. The aim of this review is to call attention to the variations during the interpretation of the results of conventional (routine) laboratory tests, and to discuss the importance of some novel tests in recognizing patients at high risk and so increasing the efficiency of the therapy.
Keywords: systemic inflammatory response syndrome, routine laboratory tests, novel markers

CITATION

Aral H. Laboratory in Diagnosis and Monitoring of Systemic Inflammatory Response Syndrome or Sepsis. Eur J Basic Med Sci. 2015;5(1):10-20. https://doi.org/10.15197/sabad.2.5.02

REFERENCES

  • Hotchkiss RS, Monneret G,Payen D. Sepsis-induced immunosuppression: from cellular dysfunctions to immunotherapy. Nature 2013;13:862-74.
  • Vincent JL, Wendon J, Groeneveld J, Marshall JC, Streat S, Carlet J. The PIRO concept: O is for organ dysfunction. Crit Care 2003;7:260-4.
  • Opal SM, Glück T. Endotoxin as a drug target. Crit Care Med 2003;31(1 Suppl):S57-64.
  • Rittirsch D, Flierl MA, Ward PA. Harmful molecular mechanisms in sepsis. Nature 2008;8:776-87.
  • Huber-Lang M, Sarma JV, Zetoune FS, et al. Generation of C5a in the absence of C3: a new complement activation pathway. Nat Med 2006;12:682-7.
  • Bianchi ME. DAMPs, PAMPs and alarmins: all we need to know about danger. J Leukoc Biol 2007;81:1-5.
  • Hawlisch H, Belkaid Y, Baelder R, Hildeman D, Gerard C, Köhl J. C5a negatively regulates toll-like receptor 4-induced immune responses. Immunity 2005;22:415-26.
  • Rittirsch D, Flierl MA, Nadeau BA, et al. Functional roles for C5a receptors in sepsis. Nat Med 2008;14:551-7.
  • Xu X, Sun B. Platelet granule secretion mechanisms: Are they modified in sepsis? Thromb Res 2015;136:845-50.
  • Hotchkiss RS, Nicholson DW. Apoptosis and caspases regulate death and inflammation in sepsis. Nat Rev Immunol 2006;6:813-22.
  • Rao LV, Pechet L. Wallach’s Interpretation of Diagnostic Tests. Williamson MA, Snyder LM, ed. Laboratory tests. Philadelphia: Lippincott Williams & Wilkins, 2015:765-1202.
  • Coşkun A, Aral H, Güvenen G, Gültepe M. Farklı Düzeylerdeki Hemolizin Sodyum Ölçüm Yöntemlerine Etkisi. Türk Klinik Biyokimya Derg 2005;3:1-7.
  • Rao LV, Mitchell MJ. Wallach’s Interpretation of Diagnostic Tests. Williamson MA, Snyder LM, ed. Respiratory, metabolic, and acid-base disorders. Philadelphia: Lippincott Williams & Wilkins, 2015:672-729.
  • Dikmen Y. İstanbul Üniversitesi Cerrahpaşa Tıp Fakültesi Sürekli Tıp Eğitimi Etkinlikleri No: 70, İç Hastalıklarında Aciller. Altıparmak MR, ed. Akut Solunum Yetmezliği. İstanbul: Doyuran matbaası, 2010:67-78.
  • Murray RK, Granner DK. Harper’s illustrated biochemistry. Murray RK, Bender DA, Botham KM, Kennelly PJ, Rodwell VW, Weil PA: ed. Membranes: Structure & Function. The McGraw-Hill Companies, Inc., 2012:459-77.
  • Erk O. Acil metabolik hastalıklar. Sepsis ve septik şok. İstanbul: Ecem Basın Yayın, 2014: 429-70.
  • Berry R, Gillen F. Clinical Biochemistry Metabolic and Clinical Aspects. Marshall WJ, Lapsley M, Day AP, Ayling RM, ed. Metabolic response to stress, Edinburg: Churchill Livingstone Elsevier, 2014:429.
  • Dellinger RP, Levy MM, Rhodes A, et al.; Djillali; and the Surviving Sepsis Campaign Guidelines Committee including the Pediatric Subgroup Surviving Sepsis Campaign: International Guidelines for Management of Severe Sepsis and Septic Shock: 2012. Crit Care Med 2013;41:580-637.
  • Türk Hematoloji Derneği http://www.thd.org.tr/thd-Data/userfiles/file/YDPS-10-5-2100.pdf (erişim tarihi: 09.12.2015).
  • Chiesa C, Panero A, Osborn JF, et al. Diagnosis of neonatal sepsis: a clinical and laboratory challenge. Clin Chem 2004; 50: 279-87.
  • Gerdes JS. Diagnosis and management of bacterial infections in neonate. Pediatr Clin N Am 2004;51: 939-59.
  • Öztürk M. Adnan. Enfeksiyon Hastalıkları. In: Yurdakök M, Erdem G (eds). Türk Neonatoloji Derneği Neonatoloji. Ankara 2004 ; 354-83.
  • Monroe BL, Weinberg AG, Rosenfeld CR, et al. The neonatal blood count in health and disease. Reference values for neutrophilic cells. J Pediatr, 1979;95:89-98.
  • Bick RL. Disseminated intravascular coagulation: objective clinical and laboratory diagnosis, treatment, and assessment of therapeutic response. Semin Thromb Hemost(abst) 1996;22:69-88.
  • Horan JT, Francis CW. Fibrin degradation products, fibrin monomer and soluble fibrin in disseminated intravascular coagulation. Semin Thromb Hemost 2001; 27: 657-66.
  • Cate TH, Sommejer DW, Levy M. Disseminated intravascular caogulation in the new millennium. Hematol J 2002;3:86-95.
  • Günay Ü, Baytan B, Meral Güneş A, Bör Ö. Yaygın Damar içi Pıhtılaşması. Güncel Pediatri 2004;2:117-21.
  • Xu C, Chang A, Hack BK, Eadon MT, Alper SL, Patrick N. TNF-mediated damage to glomerular endothelium is an important determinant of acute kidney injury in sepsis. Cunningham Kidney Int 2014;85:1-19.
  • DuClos T. Function of C-reactive protein. Ann Med, 2000;32:274-8.
  • Volante E, Moretti S, Pisani F, Bevilacqua G. Early diagnosis of bacterial infection in the neonate. J. Matern Fetal Neonatal Medicine 2004; 16 (suppl 2): 13-6.
  • Benitz W, Han M, Madan A, et al. Serial serum C-reactive protein levels in the diagnosis of neonatal infection. Pediatrics, 1998;102:e41.
  • Yılmaz C, Dilmen U, Kaya İS, Uysal F, Önal E. Yenidoğan sepsis tanısında CRP, IL-6 ve prokalsitoninin karşılaştırılması. Tıp Araştırmaları Dergisi 2009;7:151-6.
  • Bilgili B, Cinel İ. Yoğun bakım hastalarında ‘Soluble Urokinase Plasminogen Activator Receptor (suPAR)’ın önemi. J Turk Soc Intens Care 2013;11:33-9.
  • Marshall JC, Reinhart K; International Sepsis Forum. Biomarkers of sepsis. Crit Care Med 2009;37:2290-8.
  • Wang X, Li ZY, Zeng L, et al. Neutrophil CD64 expression as a diagnostic marker for sepsis in adult patients: a metaanalysis. Crit Care 2015;19:245.
  • Lau C, Olstad OK, Holden M, et al. Gene expression profiling of Gram-negative bacteria-induced inflammation in human whole blood: The role ofcomplement and CD14-mediated innate immune response. Genom Data 2015;5:176-83.
  • Uludağ Yanaral T. Yoğun bakım hastalarında prokalsitonin ve C-reaktif proteinin prognostik anlamının APACHE II ve SOFA skorlarıyla karşılaştırılarak değerlendirilmesi (uzmanlık tezi). T.C. S. B. Haseki EAH, 1. Anesteziyoloji ve Reanimasyon Kliniği, tez danışmanları: Uz. Dr. Kadir İdin, Uz. Dr. Sinan Uzman. İstanbul, 2009:13-33.
  • Lee WJ, Woo SH, Kim DH, et al. Are prognostic scores and biomarkers such as procalcitonin the appropriate prognostic precursors for elderly patients with sepsis in the emergency department? Aging Clin Exp Res. 2015 [Epub ahead of print].
  • Carrol ED, Thomson APJ, Hart CA. Procalcitonin as a marker of sepsis. Int J Antimicrob Agents 2002; 20:1-9.
  • Okamura Y. Usefulness of Presepsin Measurement: A New Biomarker for Sepsis. Rinsho Byori 2015;63:62-71.
  • Mussap M, Puxeddu E, Puddu M, et al. Soluble CD14 subtype (sCD14-ST) presepsin in premature and full term critically ill newborns with sepsis and SIRS. Clin Chim Acta 2015;451(Pt A):65-70.
  • Yilmaz H, Cakmak M, Inan O, Darcin T, Akcay A. Can neutrophil-lymphocyte ratio be independent risk factor for predicting acute kidney injury in patients with severe sepsis? Ren Fail 2015;37:225-9.
  • Gurol G, Ciftci IH, Terzi HA, Atasoy AR, Ozbek A, Koroglu M. Are there standardized cutoff values for neutrophillymphocyte ratios in bacteremia or sepsis? J Microbiol Biotechnol 2015;25: 521-5.
  • Terradas R, Grau S, Blanch J, et al. Eosinophil count and neutrophil-lymphocyte count ratio as prognostic markers in patients with bacteremia: A retrospective cohort study. PLoS ONE 2012;7:e42860.
  • Kurtipek E, Bekci TT, Kesli R, Erdem SS, Terzi Y. The role of neutrophil-lymphocyte ratio and platelet-lymphocyte ratio in exacerbation of chronic obstructive pulmonary disease. J Pak Med Assoc 2015;65:1283-7.
  • Mardi D, Fwıty B, Lobmann R, Ambrosch A. Mean cell volume of neutrophils and monocytes compared with C-reactive protein, interleukin-6 and white blood cell count for prediction of sepsis and nonsystemic bacterial infections. Int Jnl Lab Hem 2010;32:410-8.
  • Chaves F, Tierno B, Xu D. Neutrophil Volume Distribution Width: A New Automated Hematologic Parameter for Acute Infection. Arch Pathol Lab Med 2006;130:378–80.
  • Kim H, Kim Y, Lee HK, Kim KH, Yeo CD. Comparison of the delta neutrophil index with procalcitonin and C-reactive protein in sepsis. Clin Lab 2014;60:2015-21.
  • Seok Y, Choi JR, Kim J, et al. Delta neutrophil index: a promising diagnostic and prognostic marker for sepsis. Shock 2012;37:242-6.
  • Park BH, Kang YA, Park MS, et al. Delta neutrophil index as an early marker of disease severity in critically ill patients with sepsis. BMC Infect Dis 2011;11:299.
  • Fernandes B, Hamaguchi Y. Automated enumeration of immature granulocytes. Am J Clin Pathol 2007;128:454-63.
  • Nierhaus A, Klatte S, Linssen J, et al. Revisiting the white blood cell count: immature granulocytes count as a diagnostic marker to discriminate between SIRS and sepsis--a prospective, observational study. BMC Immunol 2013;14:8.
  • Kaya Z. Tam kan sayım çıktılarının yorumlanması. Dicle Tıp Dergisi 2013;40:521-8.
  • Toh CH, Samis J, Downey C, et al. Biphasic transmittance waveform in theAPTT coagulation assay is due to the formation of a Ca++ -dependent complex of C-reactive protein with very-low–density lipoprotein and is a novel marker of impending disseminated intravascular coagulation. Blood 2002;100:2522-9.
  • Dempfle CE, Lorenz S, Smolinski M, et al. Utility of activated partial thromboplastin time waveform analysis for identification of sepsis and overt disseminated intravascular coagulation in patients admitted to a surgical intensive care unit. Crit Care Med 2004;32:520-4.
  • Zakariah AN, Cozzi SM, Van Nuffelen M, Clausi CM, Pradier O, Vincent JL. Combination of biphasic transmittance waveform with blood procalcitonin levels for diagnosis of sepsis in acutely ill patients. Crit Care Med 2008;36:1507-12.
  • Hagg D, Malkoski S, Phillips C, Nichols D, Jacoby D. The biphasic aPTT waveform to diagnose sepsis in patients with systemic inflammatory response syndrome. Critical care 2007;11(Suppl 2):P51.
  • Chopin N, Floccard B, Sobas F, et al. Activated partial thromboplastin time waveform analysis: a new tool to detect infection? Crit Care Med 2006;34:1654-60.
  • Vincent JL. Sepsis and Non-infectious Systemic Inflammation. Cavaillon JM, Adrie C, ed. Definition of Sepsis and Non-infectious SIRS. Weinheim: WILEY-VCH Verlag GmbH & Co. KGaA, 2009:3-12.
  • Van Dreden P, Woodhams B, Rousseau A, Dreyfus JF, Vasse M. Contribution of procoagulant phospholipids, thrombomodulin activity and thrombin generation assays as prognostic factors in intensive care patients with septic and non-septic organ failure. Clin Chem Lab Med 2013;51:387-96.
  • Campbell JE, Aden JK, Cap AP. Acute traumatic coagulopathy: Whole blood thrombelastography measures the tip of the iceberg. J Trauma Acute Care Surg 2015;78:955-61.
  • Ak K, Atalan N, Tekeli A, et al. Tromboelastografi ve kalp cerrahisinde kullanımı. Anadolu Kardiyol Derg 2008;8:154-62.
  • Sharawy N, Lehmann C. New directions for sepsis and septic shock research. J Surg Res 2015;194:520-7.
  • Sirvent JM, Ferri C, Baró A, Murcia C, Lorencio C. Fluid balance in sepsis and septic shock as a determining factor of mortality. Am J Emerg Med 2015;33:186-9.
  • Anil AB, Anil M, Yildiz M, et al. The importance of microalbuminuria in predicting patient outcome in a PICU. Pediatr Crit Care Med 2014;15:e220-5.
  • Kuwabara A, Satoh M, Tomita N, et al. Deterioration of glomerular endothelial surface layer induced by oxidative stress is implicated in altered permeability of macromolecules in Zucker fatty rats. Diabetologia 2010;53:2056-65.
  • MD Hulett, C Freeman, BJ Hamdorf, et al. Cloning of mammalian heparanase, an important enzyme in tumor invasion and metastasis. Nat Med 1999;5:803-9.
  • Vlodavsky I, Friedmann Y, Elkin M, et al. Mammalian heparanase: gene cloning, expression and function in tumor progression and metastasis. Nat Med 1999;5:793–802.
  • Schmidt EP, Yang Y, Janssen WJ, et al. The pulmonary endothelial glycocalyx regulates neutrophil adhesion and lung injury during experimental sepsis. Nat Med 2012;18:1217-23.
  • Mikacenic C, Hahn WO, Price BL, et al. Biomarkers of Endothelial Activation Are Associated with Poor Outcome in Critical Illness. PLoS One 2015;10:e0141251.
  • Appavu SK. Differential diagnosis by metabolic profile: a dream or reality? Crit Care Med 2014;42:1300-2.
  • Mylonakis E, Clancy CJ, Ostrosky-Zeichner L, et al. T2 magnetic resonance assay for the rapid diagnosis of candidemia in whole blood: a clinical trial. Clin Infect Dis 2015;60:892-9.
  • Mickiewicz B, Tam P, Jenne CN, et al. Integration of metabolic and inflammatory mediator profiles as a potential prognostic approach for septic shock in the intensive care unit. Crit Care 2015;19:11.
  • Garcia-Simon M, Morales JM, Modesto-Alapont V, et al. Prognosis Biomarkers of Severe Sepsis and Septic Shock by 1H NMR Urine Metabolomics in the Intensive Care Unit. PLoS One 2015;10:e0140993.
  • Raghupathi W, Raghupathi V. Big data analytics in healthcare: promise and potential. Health Inf Sci Syst 2014; 2:3.